The new tool detects the evolutionary advantages of multiple myeloma cells over the different treatments available. The information it provides can help prevent the tumour from becoming resistant to d...
Read more
The Phase I/II ADCElerate-01 trial is designed to evaluate the safety, pharmacokinetics, and preliminary efficacy of ADCE-D01 as a monotherapy in patients with metastatic and/or unresectable STS
Read more
El equipo ha llegado a la conclusión de que la transformación maligna necesita reunir seis de las características epigenéticas en algún grado, desde cambios en el estado de metilación del ADN ha...
Read more
It has been developed a new pharmacological tool capable of simultaneously administering three oligonucleotide-based drugs, each acting against a different therapeutic target within the cell
Read more
This pioneering test aids oncologists in predicting recurrence and survival rates in breast cancer patients and potential eligibility for bisphosphonate treatment.
Read more
Each year, on October 9th, Nanotechnology Day is celebrated, a discipline dedicated to understanding and utilizing matter at a nanometric scale for purposes such as industrial or medical applications....
Read more
It is a simple web application for healthcare professionals to use Based on clinical and laboratory information readily available at the time of admission that it accurately predicts the 90-day mortal...
Read more
El estudio, realizado por científicos del Cima Universidad de Navarra, contribuye al desarrollo de mejores herramientas para estudiar la inmunidad antitumoral de los pacientes en el laboratorio.
Read more
Los resultados sugieren el desarrollo de un sistema de predicción de recaídas mediante IA y el uso de la biopsia líquida para identificar y caracterizar pacientes con alto riesgo, lo que permitirá...
Read more
El Hospital Clínico San Carlos ha incorporado la biopsia percutánea mediante mamografía con contraste para el diagnóstico del cáncer de mama, completando así el arsenal diagnóstico y terapéuti...
Read more
A study just published in the journal Cell Death Discovery describes for the first time the key role of fatty acid synthase (FASN) in the ability of the immune system to destroy tumors.
Read more
La Comunidad de Madrid ha sido pionera en España en el uso de una terapia de Medicina Nuclear para el abordaje del cáncer de piel no melanoma. Este tratamiento, desarrollado en el Hospital público ...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
